The advancement of personalized medicine is changing the approach to lung cancer treatment--and leading to more effective results. In this podcast, Dr. Melissa Johnson explains the latest developments in targeted therapies and the advantages of multidisciplinary care. Dr. Johnson’s patient, Ruth, joins the conversation to share how she has benefited from therapies tailored specifically to her tumor.
|
Melissa L. Johnson, MD
Thoracic Oncologist, Northwestern Memorial Hospital
Dr. Melissa Johnson is a thoracic oncologist at Northwestern Memorial Hospital and an Assistant Professor at Northwestern University Feinberg School of Medicine in the Department of Medicine, Division of Oncology/Hematology. Dr. Johnson attended medical school at the University of Pennsylvania and completed her Internship and Residency in Internal Medicine at the Weill Cornell Medical Center/New York Presbyterian Hospital. She completed...
more >
|
|
|
|
Ruth Ashton,
Lung Cancer Patient
After a small hernia repair in 2010, 46-year-old Ruth Ashton began to experience groin pain while walking. What was originally believed to be a compression fracture was actually reveled to be bone metastasis. Ruth spent a week at Northwestern Memorial Hospital, and after several scans and X-rays, it was discovered that she had lung cancer that had spread to the...
more >
|
|
|

